139 related articles for article (PubMed ID: 18652765)
1. Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer.
Tian X; Cong M; Zhou W; Zhu J; Liu Q
J Int Med Res; 2008; 36(4):699-703. PubMed ID: 18652765
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
Wu G; Zhou Y; Li T; Guo J; Zhou Z
J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
4. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma.
Selemetjev S; Savin S; Paunovic I; Tatic S; Cvejic D
J Cancer Res Ther; 2018; 14(Supplement):S114-S119. PubMed ID: 29578160
[TBL] [Abstract][Full Text] [Related]
5. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
Wang T; Jiang CX; Li Y; Liu X
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
[TBL] [Abstract][Full Text] [Related]
6. Relationship between expression of vascular endothelial growth factor and cervical lymph node metastasis in papillary thyroid cancer: A meta-analysis.
Huang XQ; He WS; Zhang HQ; Yang R; Huang T
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):661-666. PubMed ID: 29058277
[TBL] [Abstract][Full Text] [Related]
7. Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma.
Šelemetjev S; Ðoric I; Paunovic I; Tatic S; Cvejic D
Am J Clin Pathol; 2016 Nov; 146(5):594-602. PubMed ID: 27806941
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma].
Jiang HG; Gao M; Tang WP; Li FH; Cai QZ
Ai Zheng; 2005 Sep; 24(9):1136-9. PubMed ID: 16159441
[TBL] [Abstract][Full Text] [Related]
9. Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years).
Zhang ZQ; Han YZ; Nian Q; Chen G; Cui SQ; Wang XY
PLoS One; 2015; 10(12):e0144376. PubMed ID: 26656588
[TBL] [Abstract][Full Text] [Related]
10. High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis.
Pu Y; Wang L; Wu H; Feng Z; Wang Y; Guo C
Oncol Rep; 2014 Jun; 31(6):2644-50. PubMed ID: 24700287
[TBL] [Abstract][Full Text] [Related]
11. Correlation between calcification and bone sialoprotein and osteopontin in papillary thyroid carcinoma.
Wu G; Guo JJ; Ma ZY; Wang J; Zhou ZW; Wang Y
Int J Clin Exp Pathol; 2015; 8(2):2010-7. PubMed ID: 25973097
[TBL] [Abstract][Full Text] [Related]
12. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
Wang N; Jiang R; Yang JY; Tang C; Yang L; Xu M; Jiang QF; Liu ZM
J Mol Histol; 2014 Aug; 45(4):391-9. PubMed ID: 24276590
[TBL] [Abstract][Full Text] [Related]
13. [Expression of COX-2 and VEGF-C in papillary thyroid carcinoma and their relationship to cervical lymph metastases].
Miao A; Wan M; Cheng L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Oct; 23(19):881-3. PubMed ID: 20120873
[TBL] [Abstract][Full Text] [Related]
14. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
Zheng SQ; Huang RQ; Zhang YJ
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Meng XY; Zhang Q; Li Q; Lin S; Li J
J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of VEGF-C and VEGF-D in differentiated thyroid carcinoma].
Luo H; Li J; Yang T; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 23(12):531-4. PubMed ID: 19771906
[TBL] [Abstract][Full Text] [Related]
17. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
Paulson L; Shindo M; Schuff K; Corless C
Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
[TBL] [Abstract][Full Text] [Related]
18. VEGF-C and COX-2 expression in papillary thyroid cancer.
Siironen P; Ristimäki A; Narko K; Nordling S; Louhimo J; Andersson S; Haapiainen R; Haglund C
Endocr Relat Cancer; 2006 Jun; 13(2):465-73. PubMed ID: 16728574
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin-2 expression in papillary thyroid carcinoma: correlation with VEGF-D expression, lymph node metastasis, and VEGF-D-induced aggressive cancer cell phenotype.
Yasuoka H; Kodama R; Hirokawa M; Takamura Y; Miyauchi A; Inagaki M; Sanke T; Nakamura Y
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1857-61. PubMed ID: 21880798
[TBL] [Abstract][Full Text] [Related]
20. Preoperative serum VEGF-C but not VEGF-A level is correlated with lateral neck metastasis in papillary thyroid carcinoma.
Jang JY; Kim DS; Park HY; Shin SC; Cha W; Lee JC; Wang SG; Lee BJ
Head Neck; 2019 Aug; 41(8):2602-2609. PubMed ID: 30843635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
